Strategies for Effective Pain Management in Clinical Practice
Strategies for Effective Pain Management in Clinical Practice is a 3-part curriculum which examines the full spectrum of pain management options available to clinicians, including the safe and effective use of opioids. This curriculum is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
Part 1 of this series, Assessing Pain and Initiating Non-Opioid Pain Management, focuses on improving clinicians’ ability to recognize, diagnose, and classify pain, while educating clinicians on nonpharmacologic and nonopioid pharmacologic treatment options.
Part 2, Reducing Risks with Opioid Use, focuses on improving clinicians’ ability to assess potential risk factors for abuse and opioid use disorder/addiction. Clinicians will also review best practices to reduce the risks associated with prescription of opioid analgesics, information about safe opioid prescribing, as well as safe storage and disposal.
Part 3, Approaches to Opioid Treatment and Counseling Patients, will focus on providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn counseling strategies, including counseling about the use of naloxone for opioid overdose and how to recognize opioid use disorder and act appropriately to treat or refer patients.
This curriculum is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies.
This program is available as a bundle or through these individual courses:
- Discuss all options for pain management, including non-pharmacologic and pharmacologic approaches
- Explain the definitions and mechanisms of pain
- Identify the appropriate pain assessment and assessment of potential risk factors for abuse and opioid use disorder/addiction
- Develop individualized treatment plans which appropriately integrate opioids to meet the needs of patients
- Recognize best practices to reduce the risks associated with prescription of opioid analgesics, as well as safe storage and disposal
- Summarize counseling strategies, including counseling about the use of naloxone for opioid overdose
- Recognize opioid use disorder and act appropriately to treat or refer those patients
Charles E. Argoff, MD, FABPM
Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Center
Albany Medical Center
Oscar A. de Leon-Casasola, MD
Professor of Anesthesiology and Medicine
The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
Chief, Pain Medicine and Professor of Oncology
Roswell Park Cancer Institute
Katherine E. Galluzzi, DO, CMD, FACOFP
Professor and Chair
Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation. Pri-Med Institute and Vindico Medical Education staff have no relevant financial relationships to disclose.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.
- 3.53 AANP Contact Hours
- 2.06 AANP Pharmacology Contact Hours
- 3.50 MOC
- 3.50 AMA PRA Category 1 Credit™
This course is offered through Pri-Med.
To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity.
Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch